Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Drugs 83 , 14471453 (2023)
Whilst newer formulations claim improved absorption, robust clinical outcome evidence is lacking
A Phase I/II trial (NCT05130437) for this indication has been initiated in pediatric patients to evaluate the long-term safety of mRNA-3927
Research use only (not for human or veterinary use) Get notified when it's back in stock Purity: 99% (HPLC) Batch-controlled manufacturing Secure packaging for laboratory handling Storage: Store lyophilised powder frozen for long-term stability
US$ 24.68
US$ 29.15
US$ 20.68
US$ 25.15
